169 related articles for article (PubMed ID: 30411137)
1. [Skin cancer screening in Germany: review after ten years].
Hübner J; Eisemann N; Brunßen A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1536-1543. PubMed ID: 30411137
[TBL] [Abstract][Full Text] [Related]
2. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
Stang A; Jöckel KH
Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
[TBL] [Abstract][Full Text] [Related]
3. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.
Eisemann N; Waldmann A; Holleczek B; Katalinic A
J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295
[TBL] [Abstract][Full Text] [Related]
4. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.
Katalinic A; Eisemann N; Waldmann A
Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634
[TBL] [Abstract][Full Text] [Related]
5. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
Stang A; Jöckel KH; Heidinger O
Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
[TBL] [Abstract][Full Text] [Related]
6. Systematic skin cancer screening in Northern Germany.
Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
[TBL] [Abstract][Full Text] [Related]
7. Melanoma mortality following skin cancer screening in Germany.
Boniol M; Autier P; Gandini S
BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399
[TBL] [Abstract][Full Text] [Related]
8. The many unanswered questions related to the German skin cancer screening programme.
Stang A; Garbe C; Autier P; Jöckel KH
Eur J Cancer; 2016 Sep; 64():83-8. PubMed ID: 27371911
[TBL] [Abstract][Full Text] [Related]
9. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
[TBL] [Abstract][Full Text] [Related]
10. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.
Katalinic A; Waldmann A; Weinstock MA; Geller AC; Eisemann N; Greinert R; Volkmer B; Breitbart E
Cancer; 2012 Nov; 118(21):5395-402. PubMed ID: 22517033
[TBL] [Abstract][Full Text] [Related]
11. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.
Hübner J; Waldmann A; Eisemann N; Noftz M; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
Eur J Cancer Prev; 2018 Nov; 27(6):563-569. PubMed ID: 28692584
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of a population-based skin cancer screening program: evidence from Germany.
Kaiser M; Schiller J; Schreckenberger C
Eur J Health Econ; 2018 Apr; 19(3):355-367. PubMed ID: 28353004
[TBL] [Abstract][Full Text] [Related]
13. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
Eisemann N; Waldmann A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
[TBL] [Abstract][Full Text] [Related]
14. Melanoma screening: A plan for improving early detection.
Shellenberger R; Nabhan M; Kakaraparthi S
Ann Med; 2016; 48(3):142-8. PubMed ID: 26911192
[TBL] [Abstract][Full Text] [Related]
15. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009).
Geller AC; Greinert R; Sinclair C; Weinstock MA; Aitken J; Boniol M; Capellaro M; Doré JF; Elwood M; Fletcher SW; Gallagher R; Gandini S; Halpern AC; Katalinic A; Lucas R; Marghoob AA; Nolte S; Schüz J; Tucker MA; Volkmer B; Breitbart E
Cancer Epidemiol; 2010 Jun; 34(3):355-8. PubMed ID: 20381443
[TBL] [Abstract][Full Text] [Related]
16. Routine skin cancer screening in Germany: four years of experience from the dermatologists' perspective.
Kornek T; Schäfer I; Reusch M; Blome C; Herberger K; Beikert FC; Augustin M
Dermatology; 2012; 225(4):289-93. PubMed ID: 23295723
[TBL] [Abstract][Full Text] [Related]
17. Participation and health care provision of statutory skin cancer screening in Germany - a secondary data analysis.
Anastasiadou Z; Schäfer I; Siebert J; Günther W; Reusch M; Augustin M
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):424-7. PubMed ID: 26856813
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]